Brian S. Henick - Concepedia

Author

Brian S. Henick

Columbia University Irving Medical Center ORCID

Also Known As

B. Henick, B.S. Henick, Brian Henick, Brian S Henick, Brian S. Henick

227

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Yale University Memorial Sloan Kettering Cancer Center Massachusetts General Hospital Columbia University

About

Brian S. Henick is an author at Columbia University Irving Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	679
2	Cell Biology	5	5	204
3	Immunology	5	5	458
4	Health Sciences	3	3	70
5	Pathology	3	3	181

Brian S. Henick

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels Biagio Ricciuti, Xinan Wang, Joao V. Alessi, JAMA Oncology	2022	356
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer Katherine Hastings, Helena A. Yu, Wen Wei, Annals of Oncology	2019	352
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, Clinical Cancer Research	2019	326
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis Ila Datar, Miguel F. Sanmamed, Jun Wang, Clinical Cancer Research	2019	320
Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer Howard I. Scher, Xiaoyu Jia, Kim Chi, Journal of Clinical Oncology	2011	247
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results Christine D. Palmer, Amy Rappaport, Matthew J. Davis, Nature Medicine VaccinationVaccine DevelopmentMedicineImmunologyVirology	2022	205
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer Arvind Ravi, Matthew D. Hellmann, Monica Arniella, Nature Genetics	2023	162
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results Amy Rappaport, Chrisann Kyi, Monica Lane, Nature Medicine Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2024	100
Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non–Small Cell Lung Cancer Jon Zugazagoitia, Yuting Liu, Maria Toki, Journal of Thoracic Oncology Pd-1 Pathway BlockadeMedicineImmunologyTumor ImmunityCancer Cell Biology	2019	79
Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors Shoiab Bukhari, Brian S. Henick, Robert Winchester, Cell Reports Medicine	2022	71

Page 1